Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds (Q58696993)

From Wikidata
Jump to navigation Jump to search
article
edit
Language Label Description Also known as
English
Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds
article

    Statements

    Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds (English)
    4 references
    19 September 2019
    21 December 2019
    27 October 2020
    4 February 2021
    1 reference
    21 December 2019
    1 reference
    27 October 2020
    2431
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit